tiprankstipranks
Advertisement
Advertisement

PCAIGNO Stock Latest News

Aignostics Deepens AI Pathology Capabilities With New Lung Cancer System, Platform Expansions, and Strategic Partnerships
Private CompaniesAignostics Deepens AI Pathology Capabilities With New Lung Cancer System, Platform Expansions, and Strategic Partnerships
3d ago
AIGNO
Aignostics Showcases Multimodal AI System for Lung Cancer Pathology
PremiumPrivate Companies
Aignostics Showcases Multimodal AI System for Lung Cancer Pathology
5d ago
AIGNO
Aignostics Expands AI Pathology Platforms and Showcases New Foundation Model
PremiumPrivate Companies
Aignostics Expands AI Pathology Platforms and Showcases New Foundation Model
10d ago
AIGNO
Pathology AI Model RudolfV 2 Gains Visibility on Hugging Science
PremiumPrivate Companies
Pathology AI Model RudolfV 2 Gains Visibility on Hugging Science
12d ago
AIGNO
Aignostics Deepens AI Pathology Footprint With Expanded Cancer Coverage, Open Platforms, and New Proscia Tie-Up
PremiumPrivate Companies
Aignostics Deepens AI Pathology Footprint With Expanded Cancer Coverage, Open Platforms, and New Proscia Tie-Up
17d ago
AIGNO
Aignostics Expands OpenTME Adoption and Cancer Coverage in Academic Research
PremiumPrivate CompaniesAignostics Expands OpenTME Adoption and Cancer Coverage in Academic Research
19d ago
AIGNO
Aignostics Broadens AI Pathology Portfolio With New Cancer Coverage, Clinical Debut, and Proscia Integration
Premium
Private Companies
Aignostics Broadens AI Pathology Portfolio With New Cancer Coverage, Clinical Debut, and Proscia Integration
24d ago
AIGNO
Aignostics Expands Atlas H&E-TME Cancer Coverage With Ovarian Indication
Premium
Private Companies
Aignostics Expands Atlas H&E-TME Cancer Coverage With Ovarian Indication
25d ago
AIGNO
Aignostics Showcases First Clinical AI Pathology Applications at ESP Congress
PremiumPrivate Companies
Aignostics Showcases First Clinical AI Pathology Applications at ESP Congress
26d ago
AIGNO
Aignostics Deepens AI Pathology Footprint With New Foundation Model and Proscia Integration
PremiumPrivate Companies
Aignostics Deepens AI Pathology Footprint With New Foundation Model and Proscia Integration
1M ago
AIGNO
Aignostics Releases RudolfV 2 Pathology Foundation Model for Academic Research
PremiumPrivate Companies
Aignostics Releases RudolfV 2 Pathology Foundation Model for Academic Research
1M ago
AIGNO
Aignostics Expands Tumor Microenvironment Tools and Boosts Distribution With Proscia Deal
PremiumPrivate Companies
Aignostics Expands Tumor Microenvironment Tools and Boosts Distribution With Proscia Deal
1M ago
AIGNO
Aignostics Highlights New Tumor Microenvironment Analysis Features in Atlas Platform
PremiumPrivate CompaniesAignostics Highlights New Tumor Microenvironment Analysis Features in Atlas Platform
1M ago
AIGNO
Aignostics Expands OpenTME Platform and Deepens Distribution With Proscia Partnership
Premium
Private Companies
Aignostics Expands OpenTME Platform and Deepens Distribution With Proscia Partnership
2M ago
AIGNO
Aignostics Expands OpenTME Toolkit With TME Studio for Multi-Indication Spatial Analysis
Premium
Private Companies
Aignostics Expands OpenTME Toolkit With TME Studio for Multi-Indication Spatial Analysis
2M ago
AIGNO
Aignostics Integrates AI Tumor Microenvironment Tool With Proscia’s Concentriq Platform
PremiumPrivate Companies
Aignostics Integrates AI Tumor Microenvironment Tool With Proscia’s Concentriq Platform
2M ago
AIGNO
Aignostics Highlights Robust Validation of Atlas H&E-TME AI Pathology Platform
PremiumPrivate Companies
Aignostics Highlights Robust Validation of Atlas H&E-TME AI Pathology Platform
2M ago
AIGNO
Aignostics – Weekly Recap
PremiumPrivate Companies
Aignostics – Weekly Recap
2M ago
AIGNO
Agentic AI Hackathon Underscores Aignostics’ Innovation Culture
PremiumPrivate Companies
Agentic AI Hackathon Underscores Aignostics’ Innovation Culture
2M ago
AIGNO
Aignostics – Weekly Recap
PremiumPrivate CompaniesAignostics – Weekly Recap
2M ago
AIGNO
Aignostics Highlights Validation of Atlas H&E-TME Tissue Profiling System
Premium
Private Companies
Aignostics Highlights Validation of Atlas H&E-TME Tissue Profiling System
3M ago
AIGNO
Aignostics Expands Cancer Data Platforms and Deepens AI Oncology Partnerships
Premium
Private Companies
Aignostics Expands Cancer Data Platforms and Deepens AI Oncology Partnerships
3M ago
AIGNO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >